Best Biotech Podcasts (2025)

1
The future of wildfire management 33:44

2d ago33:44

33:44

Michael Wara is a lawyer and an expert in wildfire policy who says that solutions are out there, but face financial, political, and cultural resistance. What’s needed, he says, are “whole-of-society” approaches that raise wildfire risk to the community level. In this regard, the devastation in Los Angeles in 2025 could provide the spark needed for …

1
Synbio Companies Come to Grips with the One “Omic” that Matters 34:38

1h ago34:38

34:38

Synthetic biology companies have faced a difficult few years as share prices have been battered and investment in the sector has waned. As investors and companies are readying to gather for the annual SynBioBeta conference in San Jose May 5 through 8, a new report from the bipartisan National Security Commission on Emerging Biotechnology warns that…

51
The future of pediatric development and disability 31:42

9d ago31:42

31:42

Physician and psychologist Heidi Feldman is a pioneer in the field of developmental behavioral pediatrics who says that the world’s understanding of childhood disability is changing and so too are the ways we approach it. Where once institutionalization was common, today we find integrative, family-centered approaches, charting a more humane, hopef…

1
Searching for Safer Pain Medications 39:19

7d ago39:19

39:19

Until recently, treatments for both chronic and acute pain had been an area that went for decades without the development of innovative new treatments. South Rampart Pharma is seeking to develop safer and more effective pain management therapies that avoid the liver toxicity of acetaminophen, the kidney toxicity of NSAIDs, and the abuse potential o…

1
Evolving Animal Welfare: Science, Ethics, and Innovation 30:03

8d ago30:03

30:03

Are we on the brink of a major shift in research? In this episode of Sounds of Science, Charles River experts challenge traditional approaches, exploring cutting-edge innovations that enhance animal welfare while driving scientific breakthroughs. From revolutionary non-animal testing methods to advanced behavioral management strategies, we uncover …

1
Ep177: Kevin Parker on Finding Cancer Drug Targets 58:13

10d ago58:13

58:13

Kevin Parker, CEO of Cartography Biosciences, on finding new cancer drug targets.By Timmerman Report

1
Best of: The future of female athletic health 30:25

16d ago30:25

30:25

The world of women’s sports is experiencing unprecedented growth, attention, recognition, and investment. Elite athletes including Simone Biles, Caitlin Clark, Serena Williams, and many others are having a significant impact on culture, and more women than ever are participating in both professional and recreational sports. Earlier this year, Russ …

1
Bridging the Translational Divide in Healthcare AI 27:45

14d ago27:45

27:45

The Zimin Institute for AI Solutions in Healthcare, a joint initiative between the Zimin Foundation and the Technion – Israel Institute of Technology, is seeking to accelerate the integration of AI into the life sciences. Although it is pursuing a wide range of opportunities from precision medicine to therapeutic discovery, its primary focus is on …

1
The future of legal representation 36:44

19d ago36:44

36:44

Nora Freeman Engstrom is a professor of law who says that in three-quarters of cases one or more of the parties lacks legal representation. Worse yet, often the litigants are involved in high-consequence civil cases where there is no right to a lawyer and costs are prohibitive. Some states are looking at alternatives including non-lawyer representa…

1
Seeking Long-Term Pain Relief from a Drug-Free Injection 29:10

21d ago29:10

29:10

The search for non-opioid pain relievers opioids has focused on pharmaceutical alternatives including non-steroidal anti-inflammatories, antidepressants, and anticonvulsants. Brixton Biosciences is developing Neural Ice, an injectable frozen slurry that can degenerate nerves in targeted areas and provide pain relief for extended periods. The discov…

1
Cancer Vaccines, Then and Now 34:34

22d ago34:34

34:34

Did you know that the first attempt at a cancer vaccine was all the way back in the 1800s? I am joined by Charles River experts Louise Brackenbury, Dan Rocca, and Mike Templin to discuss the fascinating science behind therapeutic cancer vaccines. Clarification: Coley’s Toxin is not a vaccine in the traditional sense, but a compound developed by Wil…

1
Ep176: David Roblin on Building a TechBio Company 1:19:28

23d ago1:19:28

1:19:28

David Roblin, CEO of London-based Relation Therapeutics, on building a techbio discovery company.By Timmerman Report

1
The future of hearing loss 34:05

26d ago34:05

34:05

Physician Tina Stankovic is an ear, nose, and throat specialist and a lover of music whose seemingly disparate pursuits — medicine and music — have led her to a groundbreaking career in hearing research. She recently worked with music legend Paul Simon during his well-publicized battle with hearing loss and he has become a vocal advocate for hearin…

1
Engaging Hard-to-Target Receptors with Antibodies that Activate 39:43

28d ago39:43

39:43

Antibodies have been powerful tools for inhibiting a targeted protein. Abalone Bio is pursuing a new class of antibody therapies called activating antibodies that can regulate cellular processes and restore their balance. One aspect that makes these rare antibodies attractive is that they can target previously undruggable G protein-coupled receptor…

1
The future of live performance 36:13

1M ago36:13

36:13

Michael Rau is a professor, theater director, and tech innovator in one. He says that today’s technologies – AI, gaming, interactive storytelling, and even email – are reshaping what performers can do on stage and how audiences experience those performances. The best of the stage has always been about reflecting life, and technology is part of how …

1
An Insider’s View of the Patent Fights that Shaped the Biotech Industry 1:11:18

1M ago1:11:18

1:11:18

Jorge Goldstein trained for a career in molecular biology and biochemistry before becoming a patent attorney, a background that positioned him to help shape patent law for the biotech industry throughout his 40-year career. In his new book Patenting Life: Tales from the Front Lines of Intellectual Property and the New Biology, Goldstein offers a hi…

1
All About Spheroids 26:54

1M ago26:54

26:54

Spheroids are three dimensional cell models that can mimic some organs, tumors, and other biological systems for drug testing. Like organoids and organs-on-a-chip, spheroids are breaking in to drug development as a promising alternative to animal models. I am joined by Madhu Lal Nag, MBS PhD from the 3D in vitro model company InSphero, to discuss t…

1
Ep175: Andy Scharenberg on in vivo CAR-T cell therapies 1:10:46

1M ago1:10:46

1:10:46

Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.By Timmerman Report

1
Best of: The future of culture 31:53

1M ago31:53

31:53

We've been thinking a lot about culture recently, and reflecting on how–whether or not we’re aware of it–culture is a force that’s always exerting influence on us. It’s typically only when we get outside of our daily routine, our city or even our country, and are confronted with new ways of doing things that we can clearly see the values, norms, an…

1
Restoring Balance to the Immune System in Allergic Diseases 28:36

1M ago28:36

28:36

Eosinophilic esophagitis is a progressive allergic disease characterized by difficulty swallowing and gastric reflux. It results from an elevated number of inflammatory immune cells in the walls of the esophagus. If left untreated, it can cause long-term complications, including scarring and difficulty swallowing. Revolo Biotherapeutics is developi…

1
The future of electronic materials 35:42

2M ago35:42

35:42

We are on the cusp of a materials revolution – in electronics, health care, and avionics – says guest engineer-scientist Eric Pop. For instance, silicon and copper have served electronics admirably for decades, he says, but at the nanoscale, better materials will be needed. Atomically thin two-dimensional semiconductors (like molybdenum disulfide) …

1
Turning Natural Killers into Off-the-Shelf Therapies for Autoimmune Disease 32:09

2M ago32:09

32:09

NK cells, part of the innate immune system, serve as the body’s first line of defense. These cells can recognize and kill abnormal or infected cells. As therapies, they have the advantage over CAR-T and other cell therapies because they can be used off-the-shelf without undergoing gene editing or other genetic modifications. They also don’t trigger…

1
Ep. 89: Rethinking Toxicology: The Future of NAMs in Agrochemicals 27:46

2M ago27:46

27:46

The agrochemical field has long relied on animal models to evaluate the safety and efficacy of substances, but there’s a growing demand to adopt new alternative methods (NAMs) that can further the industry while reducing the need for animal testing. However, questions remain as to their long-term viability. Join Robert Landsiedel, Vice President of…

1
Ep174: Najat Khan on the TechBio Movement 1:07:16

2M ago1:07:16

1:07:16

Najat Khan, chief R&D and chief commercial officer of Recursion, on using technology to improve drug discovery.By Timmerman Report

1
The future of liquid biopsy 36:38

2M ago36:38

36:38

Physician Ash Alizadeh has seen the future of disease diagnosis and monitoring. It is coursing through every patient’s veins. Traditionally, biopsies have required invasively gathering tissue – from a lung, a liver, or a fetus. Now it’s possible to look for disease without surgery. The DNA is sitting there in the bloodstream, Alizadeh tells host Ru…

1
Combining an Antibody and siRNA to Treat Hepatitis B 29:28

2M ago29:28

29:28

More than a decade after the approval of a curative therapy for hepatitis C, hepatitis B has proven more challenging to tackle. Vir Biotechnology, in collaboration with Alnylam Pharmaceuticals, is developing a promising combination approach that marries Vir’s monoclonal antibody tobivibart with Alnylam’s siRNA elebsiran. We spoke to Mark Eisner, ch…

1
The Mexico GMO Corn Controversy - Luis Ventura 34:37

2M ago34:37

34:37

This conversation explores the complex relationship between corn and Mexico, focusing on its cultural, economic, and agricultural significance. The discussion highlights the moratorium on genetically engineered (GM; GMO) corn, the public perception of biotechnology, and the impact of environmental NGOs on policy decisions. The conversation also del…

1
The Mexico GMO Corn Controversy - Luis Ventura 34:37

2M ago34:37

34:37

This conversation explores the complex relationship between corn and Mexico, focusing on its cultural, economic, and agricultural significance. The discussion highlights the moratorium on genetically engineered (GM; GMO) corn, the public perception of biotechnology, and the impact of environmental NGOs on policy decisions. The conversation also del…

1
Best of: The future of bioprinting 29:03

2M ago29:03

29:03

February is American Heart Month, and in light of that, we’re bringing back an episode about a group here at Stanford Engineering that’s developing 3D printing methods for human tissues and organs, a process known as bioprinting. Motivated in part by the critical need for heart transplants, Mark Skylar-Scott and his team are specifically working to…

1
Looking at the Promise of GLP-1 Agonists Beyond Obesity 22:20

2M ago22:20

22:20

While GLP-1 agonists have been all the rage in treating obesity, Coya Therapeutics sees potential for these therapies to address inflammatory diseases. In fact, Coya is developing its low-dose interleukin 2 in combination with several different agents. The belief is that its approach will address inflammation by targeting dysfunctional regulatory T…

1
Trailer: The Future of Everything 1:18

2M ago1:18

1:18

Welcome to Stanford Engineering's The Future of Everything, the podcast that delves into groundbreaking research and innovations that are shaping the world and inventing the future. The University has a long history of doing work to positively impact the world and it's a joy to share about the people who are doing this work, what motivates them, an…

1
Ep. 88: The Epidemiology of Cancer 31:29

2M ago31:29

31:29

How can genetic, geographic, and social considerations effect outcomes for Black women with cancer? To answer this question, I am joined this week by Dr. Lauren E. McCullough, Associate Professor in the Department of Epidemiology at the Rollins School of Public Health, and Julia Schueler, Research Director Therapeutic Area Lead Oncology for Charles…

1
The future of coronary arteries 32:37

2M ago32:37

32:37

Guest Kristy Red-Horse is a biologist who specializes in coronary artery development and disease. She says the latest advances in treatment of blockages could do away with invasive bypass surgeries in favor of growing new arteries using molecules like CXCL12, known to promote artery regrowth in mice. Red-Horse explains how leaps forward in medical …

1
An Off-the-Shelf Cancer Vaccine Faces a Final Clinical Hurdle in NSCLC 31:20

2M ago31:20

31:20

Though cancer vaccines have been an area of great promise, in practice they have faced several challenges because of the heterogeneity of tumors, the ability of the tumor microenvironment to suppress the immune system, and the challenges of producing a strong and sustained T-cell response. OSE Immunotherapeutics’ off-the-shelf cancer vaccine Tedopi…

1
Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders 57:56

2M ago57:56

57:56

Robert Blum, CEO of South San Francisco-based Cytokinetics, on building a fully integrated biopharma to treat muscle disorders.By Timmerman Report

1
The future of transparent tissue 30:03

3M ago30:03

30:03

Materials scientist and physicist Guosong Hong is an expert in getting materials to do remarkable things. Recently, he and collaborators used a common food dye found in snack chips to turn living tissue transparent, allowing light to penetrate through skin and muscle. Hong is now working to realize a new age of medical imaging that lets doctors see…

1
A Nose for Attacking Brain Cancer 8:54

3M ago8:54

8:54

One of the challenges in treating brain cancer and other diseases of the central nervous system is delivering therapeutics beyond the blood-brain barrier. NeOnc Technologies using a natural compound derived from essential oils in plants that not only can kill cancer cells, but can cross the blood-brain barrier. What’s more, it can transport other t…

1
Ep. 87: Taking a Customized and Collaborative Approach to Therapeutic Development 28:49

3M ago28:49

28:49

The N=1 Collaborative is changing the way we view drug development. Their specialty is creating customized therapies tailored to individual patients, paving the way for a unique approach that can leave long-lasting impacts on those with ultra-rare diseases. Join us as Executive Director Hugh Hempel discusses the origins of N=1, the collaborative ef…

1
Synthetic Biology and Natural Products - Dr. Philipp Zerbe 38:55

3M ago38:55

38:55

This conversation explores the intersection of natural products and synthetic biology, emphasizing the importance of science communication and outreach. Julia Ball shares her passion for connecting the public with plant science, while Dr. Philip Zerbe discusses the potential of synthetic biology in producing valuable natural products, particularly …

1
Synthetic Biology and Natural Products - Dr. Philipp Zerbe 38:55

3M ago38:55

38:55

This conversation explores the intersection of natural products and synthetic biology, emphasizing the importance of science communication and outreach. Julia Ball shares her passion for connecting the public with plant science, while Dr. Philip Zerbe discusses the potential of synthetic biology in producing valuable natural products, particularly …

1
Best of: The future of science education 30:44

3M ago30:44

30:44

With the tremendous amount of information available to us today, the ability to discern what’s reliable from what’s not is crucial to combating the spread of misinformation. In 2023, we sat down with Jonathan Osborne, an expert in science education to talk about the tools our students (and really all of us!) need to critically evaluate science news…

1
An Unnatural Approach to Undruggable Targets 24:52

3M ago24:52

24:52

Some 70 percent of potential therapeutic targets are believed to be beyond the reach of conventional small molecule therapies or biologics. Macrocyclic peptides offer a way to get at elusive targets while providing desirable characteristics of both small molecule drugs and biologics. They offer oral bioavailability, can permeate cells, and engage c…

1
Ep172: Mostafa Ronaghi on Studying Live Cells at Scale 1:20:53

3M ago1:20:53

1:20:53

Mostafa Ronaghi, co-founder and executive board member of Cellanome, on developing technology to look at live cells and cellular interactions at scale.By Timmerman Report

1
Designing New Proteins with A.I. - Stefan Van Grieken 37:08

3M ago37:08

37:08

In this episode of the Talking Biotech podcast, Dr. Kevin Folta speaks with Steph van Grieken, CEO of Cradle, about the revolutionary intersection of AI and protein engineering. They discuss the central role of proteins in biological systems, the innovative software Cradle is developing to enhance protein design, and the implications of these advan…

1
Designing New Proteins with A.I. - Stefan Van Grieken 37:08

3M ago37:08

37:08

In this episode of the Talking Biotech podcast, Dr. Kevin Folta speaks with Steph van Grieken, CEO of Cradle, about the revolutionary intersection of AI and protein engineering. They discuss the central role of proteins in biological systems, the innovative software Cradle is developing to enhance protein design, and the implications of these advan…

1
The future of seaweed 32:40

3M ago32:40

32:40

Oceanographer Kristen Davis, an authority on ocean physics and climate sustainability, discusses the growing excitement around seaweed and kelp as tools to combat climate change. Like trees on land, these underwater plants use photosynthesis to absorb carbon dioxide and convert it into organic matter. When they die, some of that carbon may sink to …

1
Expanding the Drug Developer’s Chemical Universe 33:52

3M ago33:52

33:52

Through the creation of a chemical programming language, Chemify said it has been able to expand the chemical space it can explore. Chemify is combining this unique programming language with robotics and AI to digitize chemistry. The company, though, has much grander ambitions than being a drug developer. It wants to be the infrastructure for the i…

1
Ep. 85: The Next Generation of Drug Development 26:01

3M ago26:01

26:01

Artificial intelligence and machine learning are launching a new era in drug development. By integrating these technologies, researchers can get their life-saving therapies to patients faster thanks to more accurate data and efficient processes. Join us as Brian Roche, General Manager of Charles River’s integrated toxicology site in Kansas, as he d…

1
The future of kidney dialysis 33:43

3M ago33:43

33:43

Nephrologist Manjula Tamura discusses the downsides of kidney dialysis, especially for old or frail patients. Her field has set its sights on offering alternatives, including supportive medical management without dialysis, dialysis in increments, wearable artificial kidneys, and transplanted kidneys from genetically modified pigs – in addition to a…

1
Take 100 Megabytes a Day and Call Me in the Morning 29:20

3M ago29:20

29:20

Prescription digital therapies, the use of software to treat disease, are growing in number. Already there have been 140 prescription digital therapies that have been granted market access through national regulatory and reimbursement pathways. That represents a five-fold increase in the since 2021, according to the IQVIA Digital Health Trends 2024…

Podcasts Worth a Listen

Biotech Podcasts

Podcasts Worth a Listen